India to Hong Kong: Semaglutide Export Trade Route
India has recorded 103 verified shipments of Semaglutide exported to Hong Kong, representing a combined trade value of $853.1K USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $8.3K USD. The leading Indian exporter is LOTUS INTERNATIONAL, which accounts for 41% of total export value with 14 shipments worth $352.3K USD. On the buying side, MAXIM PHARMACY is the largest importer in Hong Kong with $184.1K USD in purchases. The top 3 suppliers — LOTUS INTERNATIONAL, GMSANJIVANI LLP, GANPATI EXIM INC — together control 78% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Hong Kong Semaglutide corridor is one of India's established pharmaceutical export routes, with 103 shipments documented worth a combined $853.1K USD. The route is dominated by LOTUS INTERNATIONAL, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's semaglutide manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $8.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with semaglutide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 11.3%, placing it at rank #16 among India's top semaglutide export destinations globally.
On the import side, key buyers of Indian semaglutide in Hong Kong include MAXIM PHARMACY, TO THE-, TO THE ORDER OF CONCERNED PERSON and 24 others. MAXIM PHARMACY is the single largest importer with 6 shipments valued at $184.1K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#16
- Annual growth+11.3%
- Demand growth+10.2%
- Regulatory ease84/100
Top 10 Indian Semaglutide Exporters to Hong Kong
Showing top 10 of 12 Indian suppliers exporting Semaglutide to Hong Kong, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LOTUS INTERNATIONAL Avg $25.2K per shipment | 14 | $352.3K | 41.3% |
| 2 | GMSANJIVANI LLP Avg $6.2K per shipment | 26 | $160.6K | 18.8% |
| 3 | GANPATI EXIM INC Avg $13.5K per shipment | 11 | $148.9K | 17.5% |
| 4 | KARDI TRADING PRIVATE LIMITED Avg $74.4K per shipment | 1 | $74.4K | 8.7% |
| 5 | SAVIOUR INTERNATIONAL Avg $13.3K per shipment | 4 | $53.3K | 6.2% |
| 6 | AVALON PHARMA PRIVATE LIMITED Avg $1.4K per shipment | 21 | $29.5K | 3.5% |
| 7 | CSC PHARMACEUTICALS INTERNATIONAL Avg $4.2K per shipment | 3 | $12.7K | 1.5% |
| 8 | SHREE SSD PHARMA PRIVATE LIMITED Avg $1.7K per shipment | 6 | $10.2K | 1.2% |
| 9 | KALINDI OVERSEAS Avg $574 per shipment | 9 | $5.2K | 0.6% |
| 10 | KALINDI OVERSEAS Avg $617 per shipment | 5 | $3.1K | 0.4% |
This table shows the top 10 of 12 Indian companies exporting semaglutide to Hong Kong, ranked by total trade value. The listed exporters are: LOTUS INTERNATIONAL, GMSANJIVANI LLP, GANPATI EXIM INC, KARDI TRADING PRIVATE LIMITED, SAVIOUR INTERNATIONAL, AVALON PHARMA PRIVATE LIMITED, CSC PHARMACEUTICALS INTERNATIONAL, SHREE SSD PHARMA PRIVATE LIMITED, KALINDI OVERSEAS , KALINDI OVERSEAS. LOTUS INTERNATIONAL is the dominant supplier with 14 shipments worth $352.3K USD, giving it a 41% market share. The top 3 suppliers together account for 78% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to Hong Kong Semaglutide export route.
Top 10 Semaglutide Importers in Hong Kong
Showing top 10 of 27 known buyers in Hong Kong receiving Semaglutide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian semaglutide in Hong Kong include MAXIM PHARMACY, TO THE-, TO THE ORDER OF CONCERNED PERSON, SMC GLOBAL LIMITED, MANAGER SHL- SUCCEED HOLDINGS LIMITED, among 27 total buyers. The largest importer is MAXIM PHARMACY, accounting for $184.1K USD across 6 shipments — representing 22% of all semaglutide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MAXIM PHARMACY | 6 | $184.1K | 21.6% |
| 2 | TO THE- | 11 | $148.9K | 17.5% |
| 3 | TO THE ORDER OF CONCERNED PERSON | 4 | $122.6K | 14.4% |
| 4 | SMC GLOBAL LIMITED | 1 | $74.4K | 8.7% |
| 5 | MANAGER SHL- SUCCEED HOLDINGS LIMITED | 12 | $67.8K | 7.9% |
| 6 | TO THE MANAGER SHL - | 5 | $57.8K | 6.8% |
| 7 | GENUINE (ASIA) CO,LTD | 1 | $35.1K | 4.1% |
| 8 | MAXIM PHARMACY | 3 | $25.0K | 2.9% |
| 9 | THE MANAGER PHARMACEUTICAL DEPARTMENT MAXIM PHARMACY ROOM | 1 | $20.7K | 2.4% |
| 10 | TO THE MANAGER SHL | 1 | $19.5K | 2.3% |
Showing top 10 of 27 Semaglutide importers in Hong Kong on this route.
Top 10 Semaglutide Formulations Imported by Hong Kong
Showing top 10 of 60 product formulations shipped on the India to Hong Kong Semaglutide route, ranked by trade value
Hong Kong imports a wide range of semaglutide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SEMAGLUTIDE 14 MG (PACK OF 10 TABS) — accounts for $168.6K USD across 5 shipments. There are 60 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SEMAGLUTIDE 14 MG (PACK OF 10 TABS) | 5 | $168.6K | 19.8% |
| 2 | SEMAGLUTIDE 7MG TABS(2188 STP) (10S PACK)NOS | 1 | $74.4K | 8.7% |
| 3 | PHARMACEUTICAL PRODUCT (MEDICINE) : PACK OF 10 TAB SEMAGLUTIDE TABLETS 14MG | 3 | $58.5K | 6.9% |
| 4 | RYBELSUS 7MG TABLETS EACH TABLET CONTAINS SEMAGLUTIDE 7 MG 600 PACKS X 10 TABS | 2 | $51.0K | 6.0% |
| 5 | PHARMACEUTICAL PRODUCT (MEDICINE) : PACK OF 10 TAB SEMAGLUTIDE TABLETS 7MG | 2 | $42.8K | 5.0% |
| 6 | RYBELSUS 14 MG (SEMAGLUTIDE 14MG) (10 TAB)NOS | 3 | $40.7K | 4.8% |
| 7 | RYBELSUS 14 MG TABLETS EACH TABLET CONTAINS SEMAGLUTIDE 14 MG 800 PACKS X 10TABS | 1 | $37.6K | 4.4% |
| 8 | RYBELSUS 14 MG COMPOSITION E.TAB.CON.SEMAGLUTIDE 14 MG EXC.SALCAPROZATE SODIUM,CELLULOSE MICROCRYSTALLINE (PH. EUR.US | 1 | $35.1K | 4.1% |
| 9 | RYBELSUS 7 MG TABLETS EACH TABLET CONTAINS SEMAGLUTIDE 7 MG 800 PACKS X 10 TABS | 1 | $34.0K | 4.0% |
| 10 | RYBELSUS 3 MG SEMAGLUTIDE 3MG 10 TAB | 2 | $31.5K | 3.7% |
Showing top 10 of 60 Semaglutide formulations imported by Hong Kong on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 63 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's semaglutide exports to Hong Kong are driven primarily by a handful of large-scale manufacturers. LOTUS INTERNATIONAL with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Hong Kong benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LOTUS INTERNATIONAL, GMSANJIVANI LLP, GANPATI EXIM INC — together account for 78% of total trade value on this route. The average shipment value of $8.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as semaglutide 7mg tabs(2188 stp) (10s pack)nos and pharmaceutical product (medicine) : pack of 10 tab semaglutide tablets 14mg, suggesting that buyers in Hong Kong tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MAXIM PHARMACY is the largest importer with 6 shipments worth $184.1K USD — representing 22% of all semaglutide imports from India on this route. A total of 27 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $853.1K
- Avg. Shipment
- $8.3K
- Suppliers
- 12
- Buyers
- 27
- Transit (Sea)
- ~34 days
- Annual Growth
- +11.3%
Related Analysis
Other Semaglutide Routes
Unlock the Full India to Hong Kong Semaglutide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 103 shipments on this route.
Frequently Asked Questions — India to Hong Kong Semaglutide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Semaglutide to Hong Kong?
The leading Indian exporters of Semaglutide to Hong Kong are LOTUS INTERNATIONAL, GMSANJIVANI LLP, GANPATI EXIM INC. LOTUS INTERNATIONAL holds the largest market share at approximately 41% of total trade value on this route.
Q What is the total value of Semaglutide exports from India to Hong Kong?
India exports Semaglutide to Hong Kong worth approximately $853.1K USD across 103 recorded shipments. The average value per shipment is $8.3K USD.
Q Which ports does India use to ship Semaglutide to Hong Kong?
The most active port of origin is SAHAR AIR with 63 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Hong Kong for Semaglutide?
The average transit time for Semaglutide shipments from India to Hong Kong is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Hong Kong Semaglutide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 11.3% with demand growth tracking at 10.2%. The route is ranked #16 among India's top Semaglutide export destinations globally.
Q How many suppliers are active on the India to Hong Kong Semaglutide route?
There are currently 12 active Indian suppliers exporting Semaglutide to Hong Kong. The market is moderately concentrated with LOTUS INTERNATIONAL accounting for 41% of total shipment value.
Q Who are the main importers of Semaglutide from India in Hong Kong?
The leading importers of Indian Semaglutide in Hong Kong include MAXIM PHARMACY, TO THE-, TO THE ORDER OF CONCERNED PERSON, SMC GLOBAL LIMITED, MANAGER SHL- SUCCEED HOLDINGS LIMITED. MAXIM PHARMACY is the largest buyer with 6 shipments worth $184.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Hong Kong export trade corridor identified from Indian Customs (DGFT) records for Semaglutide.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 27 importers in Hong Kong matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 103 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
103 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists